학술논문
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID‐19.
Document Type
Article
Author
Source
Subject
*BIOPSY
*BONE marrow
*LENGTH of stay in hospitals
*T-test (Statistics)
*DESCRIPTIVE statistics
*MANN Whitney U Test
*COVID-19
*HEMOPHAGOCYTIC lymphohistiocytosis
*
*
*
*
*
*
*
Language
ISSN
1751-5521
Abstract
The article offers information on HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19. Topics include the secondary hemophagocytic lymphohistiocytosis (sHLH) is a severe inflammatory condition characterized by hyperactivation of the immune system occurring in the settings of several disorders, and the primary infection in healthy people or after reactivation in immunosuppressed patients.